ESTRO 35 2016 S225 ______________________________________________________________________________________________________ Overall, the possibility of sparing the bowel at the cost of extra dose to the bladder and vice versa was demonstrated. The estimated change in primary tumor control for high versus low dose regimen was less than 1% for early stage tumors and approximately 5% for late stage tumors.
Purpose or Objective:
To explore the ability of quantitative prostate T2-weighted (T2-w) and apparent diffusion coefficient maps (ADC) MRI using Haralick texture features: i) to differentiate prostate cancer (PC) from healthy tissues; ii) to be correlated with Gleason score; iii) to predict biochemical recurrence after external beam radiotherapy (RT) for prostate cancer.
Material and Methods:
Tumor and prostate zones were segmented on co-registered T2-w and ADC on two pre-treatment 3.0T MRI from 83 patients with a median age 67 years (range 50-82 years) and a median pre-treatment PSA of 9.8 ng/ml (range 3.4-48.0 ng/ml). 9 (11%) tumors were localized in the transitional zone (TZ) and 74 (89%) in the peripheral zone (PZ). Tumors were clinically staged as follows: 13% of T1, 46% of T2 and 41% of T3. Gleason scores were as follows: 6 (27%), 7 (51%), 8 (20%) and 9 (2%). They were 2% of low-risk, 33% of intermediate-risk and 65% of high-risk tumors according to D'Amico risk group classification. Almost all patients received standard treatment consisting in IMRT (100%) with IGRT (94%) associated with hormonal therapy in 53% of the patients. After a median follow-up of 47 months (range 19-65 months), 11 patients had biochemical recurrence. A total of 114 greyleveled features (first order, gradient-based and second order Haralick texture characteristics) and 4 geometrical features (maximal tumor diameter, maximal tumor perimeter, maximal tumor area and tumor volume) were extracted on normalized T2-w and ADC and were analyzed. Statistical analyses were performed using Wilcoxon signedrank test, Spearman's correlation coefficient, Harrell's Cindex, Kaplan-Meier curves and univariate Cox regression analysis.
Results: i) 56 out of 57 T2-w and 46 out of 57 ADC greyleveled features were significantly different between tumor and prostate tissues in the PZ and 25 out of 57 T2-w and 37 out of 57 ADC features in the TZ (p<0.05). ii) 5 T2-w features and 4 ADC features were significantly correlated with Gleason score, all were Haralick texture features. iii) T2-w features that significantly predicted (p<0.05) biochemical recurrence were: maximal tumor diameter/perimeter/area/volume, Kirsch gradient operator, normalized mean and standard deviation of signal intensity and 8 Haralick texture features (Difference Variance, Contrast, Inverse Difference Moment, Difference Entropy, Information Measure of Correlation, Sum Average, Sum Variance and Sum of Squares). Only normalized mean value on ADC was significantly predictive of biochemical recurrence.
Conclusion: Quantitative analysis using Haralick texture characteristics on T2-w MRI are good features: i) to differentiate prostate cancer from healthy tissues, ii) for Gleason score assessment and iii) to predict biochemical recurrence after RT. Geometrical characteristics extracted from T2-w are also good predictors of biochemical recurrence after RT.
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